Vascular Endothelial Growth Factor: Regulation in the Mouse Skin Carcinogenesis Model and Use in Antiangiogenesis Cancer Therapy

Vascular Endothelial Growth Factor: Regulation in the Mouse Skin Carcinogenesis Model and Use in Antiangiogenesis Cancer Therapy Claudio J. Conti Oncologist 2002; 7(Suppl 3): 4-11 Author Information and Disclosures Target Audience: Physicians who wish to advance their current knowledge of clinical cancer medicine in cancer biology and are involved in providing patient care in a cancer care environment. Method of Physician Participation: Read course materials, complete course quiz and evaluation form (optional). Learning Objectives After completing this course, the reader should be able to: Describe mechanisms of tumor neovascularization. Identify possible targets for cancer therapy in the biologic pathways that control angiogenesis. Identify some of the drugs that are presently used in preclinical or clinical trials, as well as their targets. The NIH/FAES designates this educational activity for a maximum of 1 AMA PRA Category 1 Credits™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

CME Activity Information Accreditation CME Instructions For Credit Privacy Statement Hardware/Software Requirements Release Date: Aug. 2, 2002 Most Recent Review: June 10, 2005* Most Recent Update: June 10, 2005 Date Credit Expires: Apr. 18, 2007 Time to Complete: 1 hour Medium: Internet Online *Click here to learn more about our review process.

Click Here to return to the complete course listing of Novel Molecular Targets for Cancer Therapy